Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic
  • Search Hotels in Sunnyvale

  • ROOMS:

Biogen increases financial guidance despite 25% revenue drop

The Cambridge drug company reported in its quarterly earnings Thursday that its revenue has dropped 25% over the last year, but investors are still bullish. In fact, the Cambridge biotech has upped its financial guidance by a minimum of $2 million for the 2021 fiscal year, bolstered by its growing multiple sclerosis portfolio and an expected increase in sales of the newly approved Alzheimer's disease drug Aduhelm.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.